PIRFENIDONE CIPLA/ PIRFENEX/ CIP PIRFENIDONE (Cipla Australia Pty Ltd)
Product name
PIRFENIDONE CIPLA/ PIRFENEX/ CIP PIRFENIDONE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
134 (255 working days)
Active ingredients
pirfenidone
Registration type
New generic medicine
Indication
PIRFENIDONE CIPLA/ PIRFENEX/ CIP PIRFENIDONE is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).